ABO blood type correlates with survival on prostate cancer vaccine therapy

Immunotherapies for cancer are transforming patient care, but clinical responses vary considerably from patient to patient. Simple, inexpensive strategies to target treatment to likely responders could substantially improve efficacy while simultaneously reducing health care costs, but identification...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthana, Saddam M., Gulley, James L., Hodge, James W., Schlom, Jeffrey, Gildersleeve, Jeffrey C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741674/
https://www.ncbi.nlm.nih.gov/pubmed/26338967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741674/
https://www.ncbi.nlm.nih.gov/pubmed/26338967

Ejemplares similares